Payments For Premiums On Derivative Instruments

No definition available.

Name:	prgo_PaymentsForPremiumsOnDerivativeInstruments
Namespace Prefix:	prgo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments For Premiums On Derivative Instruments, Due In Next Fiscal Year

+ References

No definition available.

+ Details

Name:	prgo_PaymentsForPremiumsOnDerivativeInstrumentsDueInNextFiscalYear
Namespace Prefix:	prgo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Nominal or face amount used to calculate payment on derivative.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959

+ Details

Name:	us-gaap_DerivativeNotionalAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of derivative instruments of a particular group held by the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959

+ Details

Name:	us-gaap_DerivativeNumberOfInstrumentsHeld
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Aggregate loss on all derivative instruments charged against earnings during the period, before tax effects.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959

+ Details

Name:	us-gaap_LossOnDerivativeInstrumentsPretax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12027Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	prgo_DerivativeInstrumentCoveredInterestRatePeriodAxis=prgo_June12022ThroughApril12029Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	prgo_DerivativeInstrumentTermAxis=prgo_April202022ThroughDecember152024Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	prgo_DerivativeInstrumentTermAxis=prgo_April292022ThroughMarch252026Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	prgo_DerivativeInstrumentTermAxis=prgo_April222022ThroughJune152030Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=prgo_NewTermLoanBFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=prgo_NewTermLoanAFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) € in Billions				1 Months Ended		3 Months Ended		12 Months Ended
Subsequent Events (Details) € in Billions	Apr. 29, 2022 USD ($)	Apr. 29, 2022 EUR (€)	Apr. 20, 2022 USD ($)	Apr. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Jul. 02, 2022 USD ($)	Apr. 02, 2022 USD ($) brand derivative	Dec. 31, 2021 USD ($)	Apr. 03, 2022 USD ($)
Interest Rate Swap
Subsequent Event [Line Items]
Number of instruments held \| derivative							5
Foreign currency options
Subsequent Event [Line Items]
Notional amount of derivatives					$ 1,100,000,000
Loss on derivatives							$ 3,600,000	$ 20,900,000
Obligation to pay premiums					$ 25,900,000
Net Investment Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Number of instruments held \| derivative							3
Forecast \| Foreign currency options
Subsequent Event [Line Items]
Loss on derivatives						$ 12,500,000
Forecast \| Cash Flow Hedging \| June 1, 2022 Through April 1, 2027 \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	$ 875,000,000
Forecast \| Cash Flow Hedging \| Maximum \| June 1, 2022 Through April 1, 2029 \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	1,000,000,000
Forecast \| Cash Flow Hedging \| Minimum \| June 1, 2022 Through April 1, 2029 \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	812,500,000
Forecast \| April 20, 2022 Through December 15, 2024 \| Net Investment Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	300,000,000
Forecast \| April 29, 2022 through March 25, 2026 \| Net Investment Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	700,000,000
Forecast \| April 22, 2022 through June 15, 2030 \| Net Investment Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Notional amount of derivatives	500,000,000
Forecast \| HRA Pharma
Subsequent Event [Line Items]
Binding offer for acquisition	$ 1,900,000,000
New Term Loan B Facility \| Cash Flow Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Number of instruments held \| derivative							3
4.00% unsecured senior notes due November 15, 2023
Subsequent Event [Line Items]
Interest rate, stated percentage							4.00%
New Term Loan A Facility \| Cash Flow Hedging \| Interest Rate Swap
Subsequent Event [Line Items]
Number of instruments held \| brand							2
Subsequent Event \| Foreign currency options
Subsequent Event [Line Items]
Notional amount of derivatives									$ 2,000,000,000
Payments for premiums				$ 37,000,000
Subsequent Event \| HRA Pharma
Subsequent Event [Line Items]
Outstanding equity interest acquired (percent)	100.00%
Binding offer for acquisition \| €		€ 1.8
Transaction costs	$ 10,500,000
Subsequent Event \| HRA Pharma \| General and Administrative Expense
Subsequent Event [Line Items]
Transaction costs	7,000,000
Subsequent Event \| HRA Pharma \| Other Nonoperating Income
Subsequent Event [Line Items]
Transaction costs	$ 3,500,000
Subsequent Event \| Revolving Credit Facility \| Line of Credit
Subsequent Event [Line Items]
Maximum borrowing capacity			$ 1,000,000,000
Term of debt			5 years
Subsequent Event \| Secured Debt \| Line of Credit
Subsequent Event [Line Items]
Maximum borrowing capacity			$ 500,000,000
Term of debt			5 years
Subsequent Event \| Secured Debt \| Line of Credit \| New Term Loan B Facility
Subsequent Event [Line Items]
Maximum borrowing capacity			$ 1,100,000,000
Term of debt			7 years